The House is touting passage of dozens of bills that could help combat the national opioid crisis — but a small handful of companies that have spent millions lobbying Congress could reap a windfall if any of the bills become law. In a two-week legislative blitz, the House cleared several narrowly tailored measures that would … Continue reading Opioid bills could net millions for companies